Bryan Dustin Pooler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bryan Dustin Pooler has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Perry Joseph Pickhardt
Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, USA
6 shared publications Perry J. Pickhardt
Departments of Radiology, University of Wisconsin School of Medicine and Public Health, E3/311 Clinical Science Center, 600 Highland Ave., Madison, WI 53792-3252
5 shared publicationsScott B. Reeder
Department of Radiology, University of Wisconsin School of Medicine and Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI 53792-3252
4 shared publications- David H. Kim
University of Wisconsin School of Medicine and Public Health, E3/311 CSC 600 Highland Ave Madison WI 53792-3252
3 shared publications - John William Garrett
Department of Radiology, University of Wisconsin School of Medicine & Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI 53792-3252
3 shared publications Diego Hernando
Department of Radiology, University of Wisconsin School of Medicine and Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI 53792-3252
2 shared publications
Latest Publications
- Open Access
- 5 March 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (9) , 1-9
Longitudinal evaluation of intra-patient changes in computed tomography-based body composition measures
Objective: To report longitudinal intra-patient changes in CT-based body composition using fully automated AI tools in an adult patient sample. Methods: This retrospective longitudinal study included 15,616 adult patients (mean age at first CT, 53.0 ± 14.7 years; 7096 male, 8520 female) who underwent at least two abdominal CT examinations at least five years apart (mean study interval, 9.1 ± 3.3 years, range, 5.0-20.4 years) at a single academic institution between January 1, 2000 and February 28, 2021. CT examinations were not restricted based on patient setting, clinical indication, or IV contrast media use. Seven fully automated AI body composition tools quantifying vertebral trabecular attenuation, skeletal muscle area and attenuation, visceral adipose tissue (VAT) area and attenuation, subcutaneous adipose tissue (SAT) area, and VAT/SAT ratio (VSR) were applied to each patient’s first and last available abdominal CT. Change in body composition per year were determined using the first and last available CT scans. T-test and linear regression were used to assess sex and age as predictors of longitudinal body composition change, respectively. Results: Significant differences in sex-specific mean rates of change were observed for all measures ( p < 0.05) except muscle attenuation. Certain CT biomarkers showed varying rates of change among younger, middle-age, and older adults. Age significantly predicted body composition measures except VSR in female patients, although effect size was small ( R 2 values 0.002–0.040). Conclusion: There are significant age and sex-specific differences in longitudinal, intra-patient body composition changes over time.
- 5 March 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (9) , 1-9
Open AccessLongitudinal evaluation of intra-patient changes in computed tomography-based body composition measures
Objective: To report longitudinal intra-patient changes in CT-based body composition using fully automated AI tools in an adult patient sample. Methods: This retrospective longitudinal study included 15,616 adult patients (mean age at first CT, 53.0 ± 14.7 years; 7096 male, 8520 female) who underwent at least two abdominal CT examinations at least five years apart (mean study interval, 9.1 ± 3.3 years, range, 5.0-20.4 years) at a single academic institution between January 1, 2000 and February 28, 2021. CT examinations were not restricted based on patient setting, clinical indication, or IV contrast media use. Seven fully automated AI body composition tools quantifying vertebral trabecular attenuation, skeletal muscle area and attenuation, visceral adipose tissue (VAT) area and attenuation, subcutaneous adipose tissue (SAT) area, and VAT/SAT ratio (VSR) were applied to each patient’s first and last available abdominal CT. Change in body composition per year were determined using the first and last available CT scans. T-test and linear regression were used to assess sex and age as predictors of longitudinal body composition change, respectively. Results: Significant differences in sex-specific mean rates of change were observed for all measures ( p < 0.05) except muscle attenuation. Certain CT biomarkers showed varying rates of change among younger, middle-age, and older adults. Age significantly predicted body composition measures except VSR in female patients, although effect size was small ( R 2 values 0.002–0.040). Conclusion: There are significant age and sex-specific differences in longitudinal, intra-patient body composition changes over time.
- 1 March 2025
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 224 (3)
CT-Based Body Composition Measures and Systemic Disease: A Population-Level Analysis Using Artificial Intelligence Tools in Over 100,000 Patients
Background: CT-based abdominal body composition measures have shown associations with important health outcomes. Artificial intelligence (AI) advances now allow deployment of tools that measure body composition in large patient populations. Objective: To assess associations of age, sex, and common systemic diseases on CT-based body composition measurements derived using a panel of fully automated AI tools in a population-level adult patient sample. Methods: This retrospective study included 140,606 adult patients (mean age 53.1±17.6 years; 67,613 male, 72,992 female) who underwent abdominal CT at a single academic institution between January 1, 2000, and February 28, 2021. CT examinations were not restricted based on patient setting, clinical indication, or IV contrast media utilization. Thirteen fully automated AI body composition tools quantifying liver, spleen, and kidney volume and attenuation, vertebral trabecular attenuation, skeletal muscle area and attenuation, and abdominal fat area and attenuation were applied to each patient's first available abdominal CT examination. EHR review was performed to identify common systemic diseases, including cancer, cardiovascular disease (CVD), diabetes mellitus (DM), and cirrhosis, based on relevant ICD-10 codes; 64,789 (46.1%) patients had a diagnosis of at least one systemic disease. Multiple linear regression models were performed in the 118,141 (84.0%) patients with no systemic disease or a single systemic disease, to assess age, sex, and presence of systemic disease as predictors of body composition measures; effect sizes were characterized using the unstandardized regression coefficient B. Results: Multiple linear regression models using age, sex, and systemic disease as predictors were overall significant for all 13 body composition measures (all p<.001) with variable goodness of fit (R2=0.03-0.43 across models). In the models, age was predictive of all 13 body composition measures, sex of 12 measures, cancer of nine measures, CVD of 11 measures, DM of 13 measures, and cirrhosis of 12 measures (all p<.05). Conclusion: Age, sex, and the presence of common systemic diseases were predictors of AI-derived CT-based body composition measures. Clinical Impact: An understanding of the identified associations with common systemic diseases will be critical for establishing normative reference ranges as CT-based AI body composition tools are developed for clinical use.
- 1 March 2025
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 224 (3)
CT-Based Body Composition Measures and Systemic Disease: A Population-Level Analysis Using Artificial Intelligence Tools in Over 100,000 Patients
Background: CT-based abdominal body composition measures have shown associations with important health outcomes. Artificial intelligence (AI) advances now allow deployment of tools that measure body composition in large patient populations. Objective: To assess associations of age, sex, and common systemic diseases on CT-based body composition measurements derived using a panel of fully automated AI tools in a population-level adult patient sample. Methods: This retrospective study included 140,606 adult patients (mean age 53.1±17.6 years; 67,613 male, 72,992 female) who underwent abdominal CT at a single academic institution between January 1, 2000, and February 28, 2021. CT examinations were not restricted based on patient setting, clinical indication, or IV contrast media utilization. Thirteen fully automated AI body composition tools quantifying liver, spleen, and kidney volume and attenuation, vertebral trabecular attenuation, skeletal muscle area and attenuation, and abdominal fat area and attenuation were applied to each patient's first available abdominal CT examination. EHR review was performed to identify common systemic diseases, including cancer, cardiovascular disease (CVD), diabetes mellitus (DM), and cirrhosis, based on relevant ICD-10 codes; 64,789 (46.1%) patients had a diagnosis of at least one systemic disease. Multiple linear regression models were performed in the 118,141 (84.0%) patients with no systemic disease or a single systemic disease, to assess age, sex, and presence of systemic disease as predictors of body composition measures; effect sizes were characterized using the unstandardized regression coefficient B. Results: Multiple linear regression models using age, sex, and systemic disease as predictors were overall significant for all 13 body composition measures (all p<.001) with variable goodness of fit (R2=0.03-0.43 across models). In the models, age was predictive of all 13 body composition measures, sex of 12 measures, cancer of nine measures, CVD of 11 measures, DM of 13 measures, and cirrhosis of 12 measures (all p<.05). Conclusion: Age, sex, and the presence of common systemic diseases were predictors of AI-derived CT-based body composition measures. Clinical Impact: An understanding of the identified associations with common systemic diseases will be critical for establishing normative reference ranges as CT-based AI body composition tools are developed for clinical use.
- 1 January 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 310 (1) , e232007
CT Colonography Reporting and Data System (C-RADS): Version 2023 Update
The CT Colonography Reporting and Data System (C-RADS) has withstood the test of time and proven to be a robust classification scheme for CT colonography (CTC) findings. C-RADS version 2023 represents an update on the scheme used for colorectal and extracolonic findings at CTC. The update provides useful insights gained since the implementation of the original system in 2005. Increased experience has demonstrated confusion on how to classify the mass-like appearance of the colon consisting of soft tissue attenuation that occurs in segments with acute or chronic diverticulitis. Therefore, the update introduces a new subcategory, C2b, specifically for mass-like diverticular strictures, which are likely benign. Additionally, the update simplifies extracolonic classification by combining E1 and E2 categories into an updated extracolonic category of E1/E2 since, irrespective of whether a finding is considered a normal variant (category E1) or an otherwise clinically unimportant finding (category E2), no additional follow-up is required. This simplifies and streamlines the classification into one category, which results in the same management recommendation.
- 1 January 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 310 (1) , e232007
CT Colonography Reporting and Data System (C-RADS): Version 2023 Update
The CT Colonography Reporting and Data System (C-RADS) has withstood the test of time and proven to be a robust classification scheme for CT colonography (CTC) findings. C-RADS version 2023 represents an update on the scheme used for colorectal and extracolonic findings at CTC. The update provides useful insights gained since the implementation of the original system in 2005. Increased experience has demonstrated confusion on how to classify the mass-like appearance of the colon consisting of soft tissue attenuation that occurs in segments with acute or chronic diverticulitis. Therefore, the update introduces a new subcategory, C2b, specifically for mass-like diverticular strictures, which are likely benign. Additionally, the update simplifies extracolonic classification by combining E1 and E2 categories into an updated extracolonic category of E1/E2 since, irrespective of whether a finding is considered a normal variant (category E1) or an otherwise clinically unimportant finding (category E2), no additional follow-up is required. This simplifies and streamlines the classification into one category, which results in the same management recommendation.
- 1 January 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 310 (1) , e232078
Natural History of Colorectal Polyps Undergoing Longitudinal in Vivo CT Colonography Surveillance
Background The natural history of colorectal polyps is not well characterized due to clinical standards of care and other practical constraints limiting in vivo longitudinal surveillance. Established CT colonography (CTC) clinical screening protocols allow surveillance of small (6-9 mm) polyps. Purpose To assess the natural history of colorectal polyps followed with CTC in a clinical screening program, with histopathologic correlation for resected polyps. Materials and Methods In this retrospective study, CTC was used to longitudinally monitor small colorectal polyps in asymptomatic adult patients from April 1, 2004, to August 31, 2020. All patients underwent at least two CTC examinations. Polyp growth patterns across multiple time points were analyzed, with histopathologic context for resected polyps. Regression analysis was performed to evaluate predictors of advanced histopathology. Results In this study of 475 asymptomatic adult patients (mean age, 56.9 years ± 6.7 [SD]; 263 men), 639 unique polyps (mean initial diameter, 6.3 mm; volume, 50.2 mm3) were followed for a mean of 5.1 years ± 2.9. Of these 639 polyps, 398 (62.3%) underwent resection and histopathologic evaluation, and 41 (6.4%) proved to be histopathologically advanced (adenocarcinoma, high-grade dysplasia, or villous content), including two cancers and 38 tubulovillous adenomas. Advanced polyps showed mean volume growth of +178% per year (752% per year for adenocarcinomas) compared with +33% per year for nonadvanced polyps and -3% per year for unresected, unretrieved, or resolved polyps (P < .001). In addition, 90% of histologically advanced polyps achieved a volume of 100 mm3 and/or volume growth rate of 100% per year, compared with 29% of nonadvanced and 16% of unresected or resolved polyps (P < .001). Polyp volume-to-diameter ratio was also significantly greater for advanced polyps. For polyps observed at three or more time points, most advanced polyps demonstrated an initial slower growth interval, followed by a period of more rapid growth. Conclusion Small colorectal polyps ultimately proving to be histopathologically advanced neoplasms demonstrated substantially faster growth and attained greater overall size compared with nonadvanced polyps. Clinical trial registration no. NCT00204867 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Dachman in this issue.
- 1 January 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 310 (1) , e232078
Natural History of Colorectal Polyps Undergoing Longitudinal in Vivo CT Colonography Surveillance
Background The natural history of colorectal polyps is not well characterized due to clinical standards of care and other practical constraints limiting in vivo longitudinal surveillance. Established CT colonography (CTC) clinical screening protocols allow surveillance of small (6-9 mm) polyps. Purpose To assess the natural history of colorectal polyps followed with CTC in a clinical screening program, with histopathologic correlation for resected polyps. Materials and Methods In this retrospective study, CTC was used to longitudinally monitor small colorectal polyps in asymptomatic adult patients from April 1, 2004, to August 31, 2020. All patients underwent at least two CTC examinations. Polyp growth patterns across multiple time points were analyzed, with histopathologic context for resected polyps. Regression analysis was performed to evaluate predictors of advanced histopathology. Results In this study of 475 asymptomatic adult patients (mean age, 56.9 years ± 6.7 [SD]; 263 men), 639 unique polyps (mean initial diameter, 6.3 mm; volume, 50.2 mm3) were followed for a mean of 5.1 years ± 2.9. Of these 639 polyps, 398 (62.3%) underwent resection and histopathologic evaluation, and 41 (6.4%) proved to be histopathologically advanced (adenocarcinoma, high-grade dysplasia, or villous content), including two cancers and 38 tubulovillous adenomas. Advanced polyps showed mean volume growth of +178% per year (752% per year for adenocarcinomas) compared with +33% per year for nonadvanced polyps and -3% per year for unresected, unretrieved, or resolved polyps (P < .001). In addition, 90% of histologically advanced polyps achieved a volume of 100 mm3 and/or volume growth rate of 100% per year, compared with 29% of nonadvanced and 16% of unresected or resolved polyps (P < .001). Polyp volume-to-diameter ratio was also significantly greater for advanced polyps. For polyps observed at three or more time points, most advanced polyps demonstrated an initial slower growth interval, followed by a period of more rapid growth. Conclusion Small colorectal polyps ultimately proving to be histopathologically advanced neoplasms demonstrated substantially faster growth and attained greater overall size compared with nonadvanced polyps. Clinical trial registration no. NCT00204867 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Dachman in this issue.
- 27 August 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (11) , 3382-3390
Artificial intelligence tool detection of intravenous contrast enhancement using spleen attenuation
Purpose To assess the ability of an automated AI tool to detect intravenous contrast material (IVCM) in abdominal CT examinations using spleen attenuation. Methods A previously validated automated AI tool measuring the attenuation of the spleen was deployed on a sample of 32,994 adult (age ≥ 18) patients (mean age, 61.9 ± 14.7 years; 13,869 men, 19,125 women) undergoing 65,449 supine position CT examinations (41,020 with and 24,429 without IVCM by DICOM header) from January 1, 2000 to December 31, 2021. After exclusions, receiver operating characteristic (ROC) curve analysis was performed to determine the optimal threshold for binary classification of IVCM status (non-contrast vs IVCM enhanced), which was then applied to the sample. Discordant examinations (i.e., IVCM status determined by AI tool did not match DICOM header) were manually reviewed to establish ground truth. Repeat ROC curve and contingency table analysis were performed to assess AI tool performance. Results ROC analysis of the initial study sample of 61,783 CT examinations yielded AUC of 0.970 with Youden index suggesting an optimal spleen attenuation threshold of 65 Hounsfield units (HU). Manual review of 2094 discordant CT examinations revealed discordance due to DICOM header error in 1278 (61.0%) and AI tool misclassification in 410 (19.6%), with 406 (9.4%) meeting exclusion criteria. Analysis of 61,377 CT examinations in the final study sample yielded AUC of 0.999 with accuracy of 99.3% at the 65 HU threshold. Error rate for DICOM header information was 2.1% (1278/61,377) versus 0.7% (410/61,377) for the AI tool. Conclusion The automated spleen attenuation AI tool was highly accurate for detection of IVCM at a threshold of 65 HU.
- 27 August 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (11) , 3382-3390
Artificial intelligence tool detection of intravenous contrast enhancement using spleen attenuation
Purpose To assess the ability of an automated AI tool to detect intravenous contrast material (IVCM) in abdominal CT examinations using spleen attenuation. Methods A previously validated automated AI tool measuring the attenuation of the spleen was deployed on a sample of 32,994 adult (age ≥ 18) patients (mean age, 61.9 ± 14.7 years; 13,869 men, 19,125 women) undergoing 65,449 supine position CT examinations (41,020 with and 24,429 without IVCM by DICOM header) from January 1, 2000 to December 31, 2021. After exclusions, receiver operating characteristic (ROC) curve analysis was performed to determine the optimal threshold for binary classification of IVCM status (non-contrast vs IVCM enhanced), which was then applied to the sample. Discordant examinations (i.e., IVCM status determined by AI tool did not match DICOM header) were manually reviewed to establish ground truth. Repeat ROC curve and contingency table analysis were performed to assess AI tool performance. Results ROC analysis of the initial study sample of 61,783 CT examinations yielded AUC of 0.970 with Youden index suggesting an optimal spleen attenuation threshold of 65 Hounsfield units (HU). Manual review of 2094 discordant CT examinations revealed discordance due to DICOM header error in 1278 (61.0%) and AI tool misclassification in 410 (19.6%), with 406 (9.4%) meeting exclusion criteria. Analysis of 61,377 CT examinations in the final study sample yielded AUC of 0.999 with accuracy of 99.3% at the 65 HU threshold. Error rate for DICOM header information was 2.1% (1278/61,377) versus 0.7% (410/61,377) for the AI tool. Conclusion The automated spleen attenuation AI tool was highly accurate for detection of IVCM at a threshold of 65 HU.
- 1 July 2019
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 213 (1) , 90-95
Clinical Implementation of a Focused MRI Protocol for Hepatic Fat and Iron Quantification
OBJECTIVE. The purpose of this article is to describe our institutional experience with the clinical implementation of a novel focused rapid chemical shift–encoded MRI protocol specifically intende...
- 1 July 2019
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 213 (1) , 90-95
Clinical Implementation of a Focused MRI Protocol for Hepatic Fat and Iron Quantification
OBJECTIVE. The purpose of this article is to describe our institutional experience with the clinical implementation of a novel focused rapid chemical shift–encoded MRI protocol specifically intende...
- 1 March 2019
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 290 (3) , 682-690
Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study
Using chemical shift-encoded MRI, our study evaluated the longitudinal change in liver fat content in severely obese adults who underwent bariatric surgery with a preoperative very low calorie diet... PurposeTo longitudinally monitor liver fat before and after bariatric surgery by using quantitative chemical shift-encoded (CSE) MRI and to compare with changes in body mass index (BMI), weight, an...
- 1 March 2019
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 290 (3) , 682-690
Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study
Using chemical shift-encoded MRI, our study evaluated the longitudinal change in liver fat content in severely obese adults who underwent bariatric surgery with a preoperative very low calorie diet... PurposeTo longitudinally monitor liver fat before and after bariatric surgery by using quantitative chemical shift-encoded (CSE) MRI and to compare with changes in body mass index (BMI), weight, an...
- 1 January 2019
- Published by Elsevier in Academic Radiology
- Vol. 26 (1) , 30-37
Volumetric Textural Analysis of Colorectal Masses at CT Colonography
- 1 January 2019
- Published by Elsevier in Academic Radiology
- Vol. 26 (1) , 30-37
Volumetric Textural Analysis of Colorectal Masses at CT Colonography
- 1 September 2018
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 47 (3) , 667-+
MRI of the Nontraumatic Acute Abdomen: Description of Findings and Multimodality Correlation
- 1 September 2018
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 47 (3) , 667-+
MRI of the Nontraumatic Acute Abdomen: Description of Findings and Multimodality Correlation
- 17 April 2018
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 48 (6) , 1578-1585
Validation of a motion‐robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing
Background: Current chemical‐shift‐encoded (CSE) MRI techniques for measuring hepatic proton density fat fraction (PDFF) are sensitive to motion artifacts.Purpose: Initial validation of a motion‐robust 2D‐sequential CSE‐MRI technique for quantification of hepatic PDFF.Study Type: Phantom study and prospective in vivo cohort.Population: Fifty adult patients (27 women, 23 men, mean age 57.2 years).Field Strength/Sequence: 3D, 2D‐interleaved, and 2D‐sequential CSE‐MRI acquisitions at 1.5T.Assessment: Three CSE‐MRI techniques (3D, 2D‐interleaved, 2D‐sequential) were performed in a PDFF phantom and in vivo. Reference standards were 3D CSE‐MRI PDFF measurements for the phantom study and single‐voxel MR spectroscopy hepatic PDFF measurements (MRS‐PDFF) in vivo. In vivo hepatic MRI‐PDFF measurements were performed during a single breath‐hold (BH) and free breathing (FB), and were repeated by a second reader for the FB 2D‐sequential sequence to assess interreader variability.Statistical Tests: Correlation plots to validate the 2D‐sequential CSE‐MRI against the phantom and in vivo reference standards. Bland–Altman analysis of FB versus BH CSE‐MRI acquisitions to evaluate robustness to motion. Bland–Altman analysis to assess interreader variability.Results: Phantom 2D‐sequential CSE‐MRI PDFF measurements demonstrated excellent agreement and correlation (R2 > 0.99) with 3D CSE‐MRI. In vivo, the mean (±SD) hepatic PDFF was 8.8 ± 8.7% (range 0.6–28.5%). Compared with BH acquisitions, FB hepatic PDFF measurements demonstrated bias of +0.15% for 2D‐sequential compared with + 0.53% for 3D and +0.94% for 2D‐interleaved. 95% limits of agreement (LOA) were narrower for 2D‐sequential (±0.99%), compared with 3D (±3.72%) and 2D‐interleaved (±3.10%). All CSE‐MRI techniques had excellent correlation with MRS (R2 > 0.97). The FB 2D‐sequential acquisition demonstrated little interreader variability, with mean bias of +0.07% and 95% LOA of ± 1.53%.Data Conclusion: This motion‐robust 2D‐sequential CSE‐MRI can accurately measure hepatic PDFF during free breathing in a patient population with a range of PDFF values of 0.6–28.5%, permitting accurate quantification of liver fat content without the need for suspended respiration.Level of Evidence: 1Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2018;48:1578–1585
- 17 April 2018
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 48 (6) , 1578-1585
Validation of a motion‐robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing
Background: Current chemical‐shift‐encoded (CSE) MRI techniques for measuring hepatic proton density fat fraction (PDFF) are sensitive to motion artifacts.Purpose: Initial validation of a motion‐robust 2D‐sequential CSE‐MRI technique for quantification of hepatic PDFF.Study Type: Phantom study and prospective in vivo cohort.Population: Fifty adult patients (27 women, 23 men, mean age 57.2 years).Field Strength/Sequence: 3D, 2D‐interleaved, and 2D‐sequential CSE‐MRI acquisitions at 1.5T.Assessment: Three CSE‐MRI techniques (3D, 2D‐interleaved, 2D‐sequential) were performed in a PDFF phantom and in vivo. Reference standards were 3D CSE‐MRI PDFF measurements for the phantom study and single‐voxel MR spectroscopy hepatic PDFF measurements (MRS‐PDFF) in vivo. In vivo hepatic MRI‐PDFF measurements were performed during a single breath‐hold (BH) and free breathing (FB), and were repeated by a second reader for the FB 2D‐sequential sequence to assess interreader variability.Statistical Tests: Correlation plots to validate the 2D‐sequential CSE‐MRI against the phantom and in vivo reference standards. Bland–Altman analysis of FB versus BH CSE‐MRI acquisitions to evaluate robustness to motion. Bland–Altman analysis to assess interreader variability.Results: Phantom 2D‐sequential CSE‐MRI PDFF measurements demonstrated excellent agreement and correlation (R2 > 0.99) with 3D CSE‐MRI. In vivo, the mean (±SD) hepatic PDFF was 8.8 ± 8.7% (range 0.6–28.5%). Compared with BH acquisitions, FB hepatic PDFF measurements demonstrated bias of +0.15% for 2D‐sequential compared with + 0.53% for 3D and +0.94% for 2D‐interleaved. 95% limits of agreement (LOA) were narrower for 2D‐sequential (±0.99%), compared with 3D (±3.72%) and 2D‐interleaved (±3.10%). All CSE‐MRI techniques had excellent correlation with MRS (R2 > 0.97). The FB 2D‐sequential acquisition demonstrated little interreader variability, with mean bias of +0.07% and 95% LOA of ± 1.53%.Data Conclusion: This motion‐robust 2D‐sequential CSE‐MRI can accurately measure hepatic PDFF during free breathing in a patient population with a range of PDFF values of 0.6–28.5%, permitting accurate quantification of liver fat content without the need for suspended respiration.Level of Evidence: 1Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2018;48:1578–1585